
Ziditroop-TZ Injection
Marketer
Osiante Biotech
Salt Composition
Ceftazidime (1000mg) + Tazobactum (125mg)
Overview Ziditroop-TZ Injection
Combithal-TZ Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be overseen by a medical practitioner; adhere strictly to the prescribed dosage schedule. Complete the entire treatment course, regardless of symptom improvement; premature cessation compromises efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate consultation. Seek emergency medical attention for allergic reactions (skin rashes, pruritus, edema, respiratory distress). Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption is contraindicated due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Ensure adequate rest, a balanced diet, and sufficient hydration for optimal recovery. Your physician may order blood tests and imaging studies to monitor treatment response.
Primary Ingredients of Ziditroop-TZ Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Ziditroop-TZ Injection
Infections caused by bacteria
Major Benefits of Ziditroop-TZ Injection:
This medication will be administered by your physician or their associate; self-medication is strongly discouraged.
Common Side effects of Ziditroop-TZ Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Ziditroop-TZ Injection:
Administering this medication will be handled by your healthcare provider; please refrain from self-medication.
How Ziditroop-TZ Injection works:
Ziditroop-TZ Injection combines the antibiotic Ceftazidime with the beta-lactamase inhibitor Tazobactum. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial resistance mechanisms, thereby improving Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ziditroop-TZ Injection's concurrent use with alcohol presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Ziditroop-TZ Injection during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Ziditroop-TZ Injection is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Ziditroop-TZ Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Ziditroop-TZ Injection cautiously. Dosage modifications for Ziditroop-TZ Injection may be necessary. Physician consultation is advised.
LiverCAUTION
The use of Ziditroop-TZ Injection requires careful consideration in individuals with advanced hepatic impairment. Dosage modification for Ziditroop-TZ Injection might be necessary. Physician consultation is advised.
What if you forget to take Ziditroop-TZ Injection :
Omit a Ziditroop-TZ Injection dose? Seek your physician's advice.
Facts to Know About Ziditroop-TZ Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
